Wakisaka M, Takagishi H
Department of Urology, Social Insurance Funabashi Chu-Oh Hospital.
Hinyokika Kiyo. 1994 Mar;40(3):261-3.
A 62-year-old man having prostate cancer presenting with hemolytic jaundice is reported. The hemolytic jaundice was cured by diethylstilbestrol diphosphate (DES-P) treatment, but the patient died one year and two months later from relapse of prostate cancer. An autopsy confirmed the diagnosis of prostate cancer with multiple metastases. Sudden anemia caused by bone metastasis might have caused the hemolytic jaundice. DES-P cured bone metastasis and then improved anemia when associated with transfusion. Consequently, hemolytic jaundice was cured.
报告了一名62岁患有前列腺癌并伴有溶血性黄疸的男性患者。经双磷酸己烯雌酚(DES-P)治疗,溶血性黄疸得以治愈,但患者在一年零两个月后因前列腺癌复发而死亡。尸检证实为前列腺癌伴多处转移。骨转移引起的突发性贫血可能导致了溶血性黄疸。DES-P治愈了骨转移,在输血的辅助下改善了贫血状况。因此,溶血性黄疸得以治愈。